10x Genomics Blog 2026년 6월 1일 10x Genomics CEO Sells Nearly 30,000 Shares. Here's What That Means for Investors. - The Motley Fool
WuXi Biologics 2026년 6월 1일 BRIEF: WuXi Biologics maintains full-year revenue guidance for up to 17% growth - thebambooworks.com
Revvity 2026년 6월 1일 Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers - TradingView
Agilent 2026년 6월 1일 StockWatch: Agilent Shares Jump on Better than Expected Quarterly Results - Genetic Engineering and Biotechnology News
eLife 2026년 6월 1일 Mural cells protect the adult brain from hemorrhage but do not control the blood–brain barrier in developing zebrafish
eLife 2026년 6월 1일 Interplay between cohesin and TORC1 links chromosome segregation and gene expression to environmental changes
eLife 2026년 6월 1일 Distinct evolutionary trajectories of two integration centres, the central complex and mushroom bodies, across Heliconiini butterflies
eLife 2026년 6월 1일 Beta-Glucan modulates monocyte plasticity and differentiation capacity to mitigate DSS-induced colitis
FierceBiotech 2026년 5월 31일 ASCO: Lilly exec points to ‘nutty’ 100% response rate for in vivo CAR-T as justifying Kelonia buyout
FierceBiotech 2026년 5월 31일 ASCO: Revolution Medicines confident in RAS leadership as rivals square up
FierceBiotech 2026년 5월 31일 ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34%
Endpoints News 2026년 5월 31일 #ASCO26: Summit, Akeso drug reduces death by 34% in China lung cancer study